Mirtazapine is primarily used in dogs as an appetite stimulant. Originally developed as a human antidepressant, it has become one of the most commonly prescribed medications in veterinary medicine for dogs that have stopped eating or are losing weight due to illness. Veterinarians also use it for its anti-nausea effects, which makes it especially helpful for dogs dealing with conditions that cause both poor appetite and stomach upset.
Why Vets Prescribe It
The most common reason your vet will reach for mirtazapine is inappetence, the clinical term for a dog that won’t eat. This can happen with a wide range of illnesses: chronic kidney disease, liver problems, cancer, gastrointestinal conditions, or recovery from surgery. In many of these situations, getting a dog to eat again is a critical part of treatment, not just for nutrition but because prolonged fasting can worsen the underlying disease.
Mirtazapine pulls double duty because it also reduces nausea. Dogs with kidney disease or those undergoing chemotherapy often feel too nauseated to eat, even when they’re hungry. By calming the nausea signals in the brain, mirtazapine removes one of the biggest barriers to eating. Some veterinarians also prescribe it off-label for anxiety-related behavior problems, though appetite stimulation remains its primary veterinary use by a wide margin.
How It Works in a Dog’s Body
Mirtazapine works by influencing two chemical messenger systems in the brain: norepinephrine and serotonin. It boosts norepinephrine activity while selectively blocking certain serotonin receptors. Specifically, it stimulates one type of serotonin receptor (5-HT1) while blocking two others (5-HT2 and 5-HT3). The 5-HT3 receptors it blocks are the same ones targeted by dedicated anti-nausea drugs, which explains why mirtazapine suppresses nausea so effectively alongside stimulating appetite.
It’s worth noting that the exact mechanism hasn’t been fully studied in dogs. Most of what veterinarians know about how the drug works is extrapolated from human research, but clinical experience over many years has confirmed that the appetite-stimulating and anti-nausea effects translate well to canine patients.
What to Expect After Your Dog Takes It
Mirtazapine is given orally, typically once every 24 hours. The dose depends on your dog’s weight. In clinical studies, dogs under 7 kg (about 15 pounds) received 3.75 mg daily, dogs between 8 and 15 kg got 7.5 mg, dogs between 16 and 30 kg received 15 mg, and dogs over 30 kg received up to 30 mg. The median dose across studies works out to roughly 0.6 mg per kilogram of body weight per day.
Most owners notice their dog showing more interest in food within the first day or two of starting treatment. The effect is often noticeable enough that dogs who had been turning away from every meal will begin eating voluntarily. This quick turnaround is one of the reasons veterinarians favor mirtazapine over other approaches to appetite loss.
Possible Side Effects
Mirtazapine is generally well tolerated, but it can cause side effects that are important to recognize. The most common ones include:
- Sleepiness or sedation: Some dogs become noticeably drowsy, especially in the first few days.
- Vocalization: Unusual whining, howling, or barking that seems out of character.
- Agitation or restlessness: The opposite of sedation in some dogs, with pacing or an inability to settle.
- Incoordination: Wobbly or unsteady walking, sometimes called ataxia.
- Vomiting or increased drooling: Somewhat ironic for an anti-nausea drug, but it happens occasionally.
- Muscle tremors: Mild shaking or twitching.
These signs can sometimes indicate serotonin syndrome, a potentially serious condition caused by too much serotonin activity in the brain. If your dog develops a combination of agitation, tremors, incoordination, and vocalization after taking mirtazapine, contact your vet promptly. A dose reduction usually resolves the issue. Bone marrow abnormalities have been reported but are rare.
Drug Interactions to Know About
Mirtazapine has some serious interactions with other medications your dog might be taking. The most dangerous combination involves a class of drugs called MAO inhibitors. In veterinary medicine, selegiline (used to treat cognitive dysfunction in older dogs) is the most relevant one. A 14-day washout period is recommended between stopping selegiline and starting mirtazapine.
There’s also an easy-to-overlook risk with amitraz, an ingredient found in certain tick prevention products and in dips used to treat mange. Amitraz acts as an MAO inhibitor, and combining it with mirtazapine raises the risk of serotonin syndrome. If your dog wears a tick collar or uses a product containing amitraz, make sure your vet knows.
Mirtazapine should not be combined with SSRIs like fluoxetine (Prozac), which is commonly prescribed for anxiety in dogs. The combination can push serotonin levels dangerously high. If your dog is currently on any behavioral medication, that’s essential information for your vet before starting mirtazapine.
Dogs With Kidney or Liver Disease
This is where things get a bit complicated, because the dogs most likely to need mirtazapine (those with chronic kidney disease or liver problems) are also the ones who may process it differently. The drug is broken down by the liver and cleared by the kidneys, so impairment in either organ can cause the medication to build up in the body.
Formal studies evaluating how mirtazapine behaves in dogs with kidney disease haven’t been conducted yet. Veterinarians typically use clinical judgment, sometimes starting at a lower dose or spacing doses further apart for dogs with significant organ compromise. The suggested dose range for dogs with kidney disease is 0.6 to 1 mg/kg every 12 hours, but your vet may adjust this based on how your dog responds and how advanced the disease is.
How It Compares to Cat Use
If you’ve heard about mirtazapine for pets before, it may have been in the context of cats. There is actually an FDA-approved transdermal mirtazapine product (Mirataz) designed specifically for cats, applied to the inner ear flap. No equivalent FDA-approved product exists for dogs. Veterinarians prescribe mirtazapine to dogs as an off-label, or extra-label, use of the human formulation, which is legal and common in veterinary practice. Dogs receive oral tablets or capsules rather than a topical form.
Research on mirtazapine’s effectiveness is more robust in cats than in dogs, but clinical use in dogs is widespread and supported by growing evidence. A placebo-controlled trial published in Animals found that mirtazapine effectively stimulated appetite in dogs across a range of body weights, reinforcing what veterinarians have observed in practice for years.